Profile of co-occurring or secondary infections among COVID-19 patients with HBOT: a single-center retrospective study
Introduction: This study was designed to describe the profile of co-occurring or secondary infections in hospitalized coronavirus disease 2019 (COVID-19) patients undergoing hyperbaric oxygen therapy (HBOT) and those without. Methodology: Out of 716 COVID-19 patients, 79 cases of co-occurring or...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2024-11-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/20460 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849313754264633344 |
|---|---|
| author | Peixia Yu Hairu Wang Ziyang Li Junyan Zhang Shuang Wei Zhifeng Xue Bozheng Zhang Qi Mei Zhengtao Wang Yani Zhao Qing Niu Pingzhi Wang |
| author_facet | Peixia Yu Hairu Wang Ziyang Li Junyan Zhang Shuang Wei Zhifeng Xue Bozheng Zhang Qi Mei Zhengtao Wang Yani Zhao Qing Niu Pingzhi Wang |
| author_sort | Peixia Yu |
| collection | DOAJ |
| description |
Introduction: This study was designed to describe the profile of co-occurring or secondary infections in hospitalized coronavirus disease 2019 (COVID-19) patients undergoing hyperbaric oxygen therapy (HBOT) and those without.
Methodology: Out of 716 COVID-19 patients, 79 cases of co-occurring or secondary infections were included. These patients were categorized into two groups based on their usage of HBOT. The basic information and laboratory examinations, especially pathogen-related results were collected from the medical records. The rate of co-occurring or secondary infections, distribution of pathogens, infection sites, and results of antimicrobial susceptibility testing were analyzed.
Results: Among the 79 COVID-19 patients examined, there were 73 cases of infections, including 58 co-occurring infections, 14 secondary infections, and 1 mixed infection in the non-HBOT group. There were 6 cases with co-occurring or secondary infections in the HBOT group. Influenza virus was predominant in the co-occurring or secondary infections of COVID-19 patients, but it was not detected in patients undergoing HBOT. Klebsiella pneumoniae, Corynebacterium striatum, and Acinetobacter baumannii were the main strains isolated among patients with HBOT. The multidrug-resistant organisms (MDROs) strains of Escherichia coli, Klebsiella aerogenes, Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecium were detected from COVID-19 patients treated with HBOT.
Conclusions: This study described the profile of in-hospital co-occurring or secondary infections in COVID-19 patients from North China. Management of the co-occurring or secondary infections, especially MDROs infections treated with HBOT, including but not limited to COVID-19, should be strengthened.
|
| format | Article |
| id | doaj-art-b2fa3dddd3664ba09e2576c7462c759f |
| institution | Kabale University |
| issn | 1972-2680 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | The Journal of Infection in Developing Countries |
| record_format | Article |
| series | Journal of Infection in Developing Countries |
| spelling | doaj-art-b2fa3dddd3664ba09e2576c7462c759f2025-08-20T03:52:39ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802024-11-01181110.3855/jidc.20460Profile of co-occurring or secondary infections among COVID-19 patients with HBOT: a single-center retrospective studyPeixia Yu0Hairu Wang1Ziyang Li2Junyan Zhang3Shuang Wei4Zhifeng Xue5Bozheng Zhang6Qi Mei7Zhengtao Wang8Yani Zhao9Qing Niu10Pingzhi Wang11Department of Laboratory Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, 030032, ChinaDepartment of Laboratory Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, 030032, ChinaDepartment of Laboratory Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, 030032, ChinaDepartment of Clinical Epidemiology and Evidence-based Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, 030032, ChinaDepartment of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Pulmonary and Critical Care Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, 030032, ChinaEmory University College of Arts and Sciences, Atlanta, GA, USACancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, ChinaDepartment of Rehabilitation Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, 030032, ChinaDepartment of Rehabilitation Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, 030032, ChinaDepartment of Rehabilitation Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, 030032, ChinaDepartment of Rehabilitation Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, 030032, China Introduction: This study was designed to describe the profile of co-occurring or secondary infections in hospitalized coronavirus disease 2019 (COVID-19) patients undergoing hyperbaric oxygen therapy (HBOT) and those without. Methodology: Out of 716 COVID-19 patients, 79 cases of co-occurring or secondary infections were included. These patients were categorized into two groups based on their usage of HBOT. The basic information and laboratory examinations, especially pathogen-related results were collected from the medical records. The rate of co-occurring or secondary infections, distribution of pathogens, infection sites, and results of antimicrobial susceptibility testing were analyzed. Results: Among the 79 COVID-19 patients examined, there were 73 cases of infections, including 58 co-occurring infections, 14 secondary infections, and 1 mixed infection in the non-HBOT group. There were 6 cases with co-occurring or secondary infections in the HBOT group. Influenza virus was predominant in the co-occurring or secondary infections of COVID-19 patients, but it was not detected in patients undergoing HBOT. Klebsiella pneumoniae, Corynebacterium striatum, and Acinetobacter baumannii were the main strains isolated among patients with HBOT. The multidrug-resistant organisms (MDROs) strains of Escherichia coli, Klebsiella aerogenes, Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecium were detected from COVID-19 patients treated with HBOT. Conclusions: This study described the profile of in-hospital co-occurring or secondary infections in COVID-19 patients from North China. Management of the co-occurring or secondary infections, especially MDROs infections treated with HBOT, including but not limited to COVID-19, should be strengthened. https://jidc.org/index.php/journal/article/view/20460coronavirus disease-19 (COVID-19)hyperbaric oxygen therapy (HBOT)co-occurring infectionssecondary infectionsmultidrug-resistant organisms (MDROs) |
| spellingShingle | Peixia Yu Hairu Wang Ziyang Li Junyan Zhang Shuang Wei Zhifeng Xue Bozheng Zhang Qi Mei Zhengtao Wang Yani Zhao Qing Niu Pingzhi Wang Profile of co-occurring or secondary infections among COVID-19 patients with HBOT: a single-center retrospective study Journal of Infection in Developing Countries coronavirus disease-19 (COVID-19) hyperbaric oxygen therapy (HBOT) co-occurring infections secondary infections multidrug-resistant organisms (MDROs) |
| title | Profile of co-occurring or secondary infections among COVID-19 patients with HBOT: a single-center retrospective study |
| title_full | Profile of co-occurring or secondary infections among COVID-19 patients with HBOT: a single-center retrospective study |
| title_fullStr | Profile of co-occurring or secondary infections among COVID-19 patients with HBOT: a single-center retrospective study |
| title_full_unstemmed | Profile of co-occurring or secondary infections among COVID-19 patients with HBOT: a single-center retrospective study |
| title_short | Profile of co-occurring or secondary infections among COVID-19 patients with HBOT: a single-center retrospective study |
| title_sort | profile of co occurring or secondary infections among covid 19 patients with hbot a single center retrospective study |
| topic | coronavirus disease-19 (COVID-19) hyperbaric oxygen therapy (HBOT) co-occurring infections secondary infections multidrug-resistant organisms (MDROs) |
| url | https://jidc.org/index.php/journal/article/view/20460 |
| work_keys_str_mv | AT peixiayu profileofcooccurringorsecondaryinfectionsamongcovid19patientswithhbotasinglecenterretrospectivestudy AT hairuwang profileofcooccurringorsecondaryinfectionsamongcovid19patientswithhbotasinglecenterretrospectivestudy AT ziyangli profileofcooccurringorsecondaryinfectionsamongcovid19patientswithhbotasinglecenterretrospectivestudy AT junyanzhang profileofcooccurringorsecondaryinfectionsamongcovid19patientswithhbotasinglecenterretrospectivestudy AT shuangwei profileofcooccurringorsecondaryinfectionsamongcovid19patientswithhbotasinglecenterretrospectivestudy AT zhifengxue profileofcooccurringorsecondaryinfectionsamongcovid19patientswithhbotasinglecenterretrospectivestudy AT bozhengzhang profileofcooccurringorsecondaryinfectionsamongcovid19patientswithhbotasinglecenterretrospectivestudy AT qimei profileofcooccurringorsecondaryinfectionsamongcovid19patientswithhbotasinglecenterretrospectivestudy AT zhengtaowang profileofcooccurringorsecondaryinfectionsamongcovid19patientswithhbotasinglecenterretrospectivestudy AT yanizhao profileofcooccurringorsecondaryinfectionsamongcovid19patientswithhbotasinglecenterretrospectivestudy AT qingniu profileofcooccurringorsecondaryinfectionsamongcovid19patientswithhbotasinglecenterretrospectivestudy AT pingzhiwang profileofcooccurringorsecondaryinfectionsamongcovid19patientswithhbotasinglecenterretrospectivestudy |